Etrix (300381.SZ) announced that the company holds Victory Awards G...
According to Zhitong Finance App, Epitoly (300381.SZ) announced that the company holds 51% of Victory Presents GmbH (hereinafter referred to as “German VE”), and Phytobiotics Futterzatzstoffe GmbH (hereinafter referred to as “Fito Baer”) holds 49% of the shares in German VE. In order to further improve the overseas marketing network and improve the efficiency of management decisions, the company's wholly-owned subsidiary VTR Biotech PTY Limited (hereinafter referred to as “Australian VTR”) plans to use its own capital to acquire 49% of the German VE shares (hereinafter referred to as the “target shares”) held by Fito Baiao. The company signed the “German VE Share Acquisition Agreement” with Australian VTR, German VE, and Fito Baiao on May 21, 2024, local time in Germany. The consideration for the underlying equity transaction was 1,226,700 euros.
German VE specializes in the development, production, processing, packaging and sales of various enzyme preparations, as well as technical research and technical services in the field of enzyme preparations. The company now acquires minority shares in German VE through its wholly-owned subsidiary VTR in Australia, which can further strengthen the control of overseas subsidiaries, improve the efficiency of management decisions, help the company promote the implementation of overseas market expansion strategies, and enhance the company's competitiveness in the European market.